Achieve Life Sciences (ACHV) Return on Capital Employed Growth (1y) (2012 - 2018)
Achieve Life Sciences (ACHV) Return on Capital Employed Growth (1y) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 2,400.00 |
| 10 | Achieve Life Sciences | 328.83 Mn | 328.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -10,187.00 |
| Sep 30, 2018 | -37,435.00 |
| Jun 30, 2018 | -43,333.00 |
| Mar 31, 2018 | -69,910.00 |
| Dec 31, 2017 | 14,848.00 |
| Sep 30, 2017 | 16,339.00 |
| Dec 31, 2016 | 9,624.00 |
| Dec 31, 2012 | 26,086.00 |
| Sep 30, 2012 | -9,816.00 |